AntiBARTy Diffusion for Property Guided Antibody Design
Over the past decade, antibodies have steadily grown in therapeutic importance thanks to their high specificity and low risk of adverse effects compared to other drug modalities. While traditional antibody discovery is primarily wet lab driven, the rapid improvement of ML-based generative modeling has made in-silico approaches an increasingly viable route for discovery and engineering. To this end, we train an antibody-specific language model, AntiBARTy, based on BART (Bidirectional and Auto-Regressive Transformer) and use its latent space to train a property-conditional diffusion model for guided IgG de novo design. As a test case, we show that we can effectively generate novel antibodies with improved in-silico solubility while maintaining antibody validity and controlling sequence diversity.
Code (0)
등록된 구현이 없습니다.
Tasks
DiversityLanguage ModelingLanguage ModellingSpecificityMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Guided Sequence-Structure Generative Modeling for Iterative Antibody Optimization
Therapeutic antibody candidates often require extensive engineering to improve key functional and developability properties before clinical development. This can be achieved through iterative design, where starting molec…
Improving Antibody Design with Force-Guided Sampling in Diffusion Models
Antibodies, crucial for immune defense, primarily rely on complementarity-determining regions (CDRs) to bind and neutralize antigens, such as viruses. The design of these CDRs determines the antibody's affinity and speci…
DenoisingSpecificityConditional generation of antibody sequences with classifier-guided germline-absorbing discrete diffusion
Antibody therapeutics are among the most successful modern medicines, yet computationally designing antibodies with desirable binding and developability properties remains challenging. While protein language models (pLMs…
De novo antibody design with SE(3) diffusion
We introduce IgDiff, an antibody variable domain diffusion model based on a general protein backbone diffusion framework which was extended to handle multiple chains. Assessing the designability and novelty of the struct…
Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design
Machine learning (ML) has demonstrated significant promise in accelerating drug design. Active ML-guided optimization of therapeutic molecules typically relies on a surrogate model predicting the target property of inter…
Domain GeneralizationDrug DesignOut-of-Distribution GeneralizationProtein Design